Goldman Sachs
FBT icon

Goldman Sachs’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Goldman Sachs’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,348
Closed -$472K – 6708
2026
Q1 		$472K Buy
2,348
+739
+46% +$153K ﹤0.01% 5640
2025
Q4 		$332K Sell
1,609
-2,132
-57% -$426K ﹤0.01% 5812
2025
Q3 		$671K Sell
3,741
-51,311
-93% -$8.74M ﹤0.01% 5324
2025
Q2 		$8.88M Buy
55,052
+14,897
+37% +$2.37M ﹤0.01% 2863
2025
Q1 		$6.83M Sell
40,155
-3,463
-8% -$601K ﹤0.01% 3041
2024
Q4 		$7.25M Buy
43,618
+15,095
+53% +$2.58M ﹤0.01% 3081
2024
Q3 		$4.9M Buy
28,523
+8,334
+41% +$1.38M ﹤0.01% 3362
2024
Q2 		$3.11M Buy
20,189
+13,326
+194% +$2M ﹤0.01% 3587
2024
Q1 		$1.06M Buy
6,863
+5,423
+377% +$827K ﹤0.01% 4319
2023
Q4 		$228K Sell
1,440
-14
-1% -$2.01K ﹤0.01% 5105
2023
Q3 		$213K Buy
+1,454
New +$222K ﹤0.01% 5026
2023
Q1 		– Sell
-1,536
Closed -$237K – 6014
2022
Q4 		$237K Sell
1,536
-1,030
-40% -$152K ﹤0.01% 5239
2022
Q3 		$339K Buy
+2,566
New +$360K ﹤0.01% 5234
2019
Q4 		– Sell
-10,852
Closed -$1.34M – 5265
2019
Q3 		$1.34M Sell
10,852
-28,924
-73% -$3.85M ﹤0.01% 3820
2019
Q2 		$5.6M Buy
+39,776
New +$5.49M ﹤0.01% 2766
2018
Q4 		– Sell
-2,612
Closed -$414K – 5364
2018
Q3 		$414K Buy
+2,612
New +$395K ﹤0.01% 4519
2018
Q2 		– Sell
-25,810
Closed -$3.43M – 5766
2018
Q1 		$3.43M Sell
25,810
-24,500
-49% -$3.34M ﹤0.01% 3194
2017
Q4 		$6.27M Sell
50,310
-4,731
-9% -$585K ﹤0.01% 2813
2017
Q3 		$6.82M Sell
55,041
-89
-0.2% -$10.5K ﹤0.01% 2884
2017
Q2 		$6.29M Sell
55,130
-211
-0.4% -$22.7K ﹤0.01% 2872
2017
Q1 		$5.83M Buy
55,341
+5,303
+11% +$531K ﹤0.01% 2815
2016
Q4 		$4.55M Buy
50,038
+38
+0.1% +$3.56K ﹤0.01% 3136
2016
Q3 		$4.99M Sell
50,000
-1,535
-3% -$151K ﹤0.01% 3049
2016
Q2 		$4.61M Sell
51,535
-1,156
-2% -$106K ﹤0.01% 2943
2016
Q1 		$4.61M Sell
52,691
-148,307
-74% -$13.1M ﹤0.01% 2781
2015
Q4 		$22.7M Sell
200,998
-4,919
-2% -$530K 0.01% 1675
2015
Q3 		$20.9M Sell
205,917
-94,083
-31% -$11.2M 0.01% 1683
2015
Q2 		$37.2M Sell
300,000
-150,226
-33% -$18.1M 0.01% 1337
2015
Q1 		$53.2M Buy
450,226
+150,226
+50% +$17M 0.02% 1047
2014
Q4 		$30.6M Sell
300,000
-230
-0.1% -$22.5K 0.01% 1506
2014
Q3 		$27.6M Sell
300,230
-9,912
-3% -$860K 0.01% 1559
2014
Q2 		$25.5M Sell
310,142
-456,941
-60% -$34.9M 0.01% 1607
2014
Q1 		$58.8M Buy
767,083
+22,877
+3% +$1.78M 0.02% 931
2013
Q4 		$51.5M Buy
744,206
+172,186
+30% +$11.3M 0.02% 1017
2013
Q3 		$37.1M Buy
572,020
+378,520
+196% +$23.9M 0.01% 1166
2013
Q2 		$11.3M Buy
+193,500
New +$11.1M ﹤0.01% 1988

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Goldman Sachs's FBT Position: Q2 2026 in Review

Goldman Sachs sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 2,348 shares — an estimated $472K sold.

Goldman Sachs first reported a position in FBT in Q2 2013 and held it in 36 quarters. The position peaked at $58.8M in Q1 2014. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Goldman Sachs reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 2,348 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $472K.
  • Goldman Sachs first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and held it in 36 quarters.
  • Goldman Sachs's First Trust NYSE Arca Biotechnology Index Fund position peaked at $58.8M in Q1 2014.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.